6-Month Buy/Sell Trend
Buys
Sells
▶
2026-04-13
▼ 1 sell
· $39K
| Insider | Title | Type | Shares | Price | $ Value | 10b5-1 | Filed |
|---|---|---|---|---|---|---|---|
| Cook Meredith | SR. VP, GENERAL COUNSEL & SEC. | ▼ Sell | 500 | $78 | $39K | Plan | Apr 13 |
▶
2026-03-11
▼ 1 sell
· $357K
| Insider | Title | Type | Shares | Price | $ Value | 10b5-1 | Filed |
|---|---|---|---|---|---|---|---|
| Rowland Thomas Andrew | SVP, HEAD - ESTABLISHED BRANDS | ▼ Sell | 4,772 | $75 | $357K | Mar 13 |
▶
2026-03-13
▼ 2 sells
· $263K
⚡ 2 insiders
▶
2026-03-07
4 other
⚡ 4 insiders
▶
2026-03-06
▼ 2 sells
· $269K
⚡ 2 insiders
▶
2026-03-09
▼ 2 sells
· $644K
⚡ 2 insiders
▶
2026-03-05
▼ 2 sells
· $552K
2 other
▶
2026-03-03
▼ 2 sells
· $603K
⚡ 2 insiders
▶
2026-03-02
▼ 1 sell
· $31K
| Insider | Title | Type | Shares | Price | $ Value | 10b5-1 | Filed |
|---|---|---|---|---|---|---|---|
| Mutz Christopher | HEAD OF RARE DISEASE | ▼ Sell | 417 | $74 | $31K | Plan | Mar 4 |
▶
2026-02-26
9 other
⚡ 9 insiders
| Insider | Title | Type | Shares | Price | $ Value | 10b5-1 | Filed |
|---|---|---|---|---|---|---|---|
| Rowland Thomas Andrew | SVP, HEAD - ESTABLISHED BRANDS | A | 6,021 | $77 | $465K | Mar 2 | |
| CAREY STEPHEN P. | SVP & CFO | A | 22,233 | $77 | $1.7M | Mar 2 | |
| Lalwani Nikhil | PRESIDENT & CEO | A | 75,592 | $77 | $5.8M | Mar 2 | |
| Gutwerg Ori | SVP, GENERICS | A | 12,969 | $77 | $1.0M | Mar 2 | |
| Mutz Christopher | HEAD OF RARE DISEASE | A | 21,306 | $77 | $1.6M | Mar 2 | |
| Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | A | 11,116 | $77 | $858K | Mar 2 | |
| Gassert Chad | SVP - CORP. DEV. & STRATEGY | A | 11,116 | $77 | $858K | Mar 2 | |
| Cook Meredith | SR. VP, GENERAL COUNSEL & SEC. | A | 13,895 | $77 | $1.1M | Mar 2 | |
| Davis Krista | SVP, CHIEF HR OFFICER | A | 10,810 | $77 | $834K | Mar 2 |
▶
2026-02-28
8 other
⚡ 8 insiders
| Insider | Title | Type | Shares | Price | $ Value | 10b5-1 | Filed |
|---|---|---|---|---|---|---|---|
| Rowland Thomas Andrew | SVP, HEAD - ESTABLISHED BRANDS | F | 628 | $74 | $46K | Mar 2 | |
| CAREY STEPHEN P. | SVP & CFO | F | 2,773 | $74 | $205K | Mar 2 | |
| Lalwani Nikhil | PRESIDENT & CEO | F | 12,217 | $74 | $903K | Mar 2 | |
| Gutwerg Ori | SVP, GENERICS | F | 2,221 | $74 | $164K | Mar 2 | |
| Mutz Christopher | HEAD OF RARE DISEASE | F | 2,221 | $74 | $164K | Mar 2 | |
| Gassert Chad | SVP - CORP. DEV. & STRATEGY | F | 2,221 | $74 | $164K | Mar 2 | |
| Cook Meredith | SR. VP, GENERAL COUNSEL & SEC. | F | 1,555 | $74 | $115K | Mar 2 | |
| Davis Krista | SVP, CHIEF HR OFFICER | F | 1,555 | $74 | $115K | Mar 2 |
▶
2026-02-20
▼ 2 sells
· $550K
⚡ 2 insiders
▶
2026-02-19
▼ 1 sell
· $162K
| Insider | Title | Type | Shares | Price | $ Value | 10b5-1 | Filed |
|---|---|---|---|---|---|---|---|
| Davis Krista | SVP, CHIEF HR OFFICER | ▼ Sell | 2,084 | $78 | $162K | Plan | Feb 23 |
▶
2026-02-12
▼ 1 sell
· $538K
8 other
⚡ 8 insiders
| Insider | Title | Type | Shares | Price | $ Value | 10b5-1 | Filed |
|---|---|---|---|---|---|---|---|
| Rowland Thomas Andrew | SVP, HEAD - ESTABLISHED BRANDS | F | 566 | $77 | $43K | Feb 17 | |
| CAREY STEPHEN P. | SVP & CFO | F | 2,829 | $77 | $217K | Feb 17 | |
| Lalwani Nikhil | PRESIDENT & CEO | F | 11,688 | $77 | $896K | Feb 17 | |
| Gutwerg Ori | SVP, GENERICS | F | 1,775 | $77 | $136K | Feb 17 | |
| Mutz Christopher | HEAD OF RARE DISEASE | F | 3,173 | $77 | $243K | Plan | Feb 17 |
| Mutz Christopher | HEAD OF RARE DISEASE | ▼ Sell | 7,032 | $77 | $538K | Plan | Feb 17 |
| Gassert Chad | SVP - CORP. DEV. & STRATEGY | F | 1,608 | $77 | $123K | Feb 17 | |
| Cook Meredith | SR. VP, GENERAL COUNSEL & SEC. | F | 1,534 | $77 | $118K | Plan | Feb 17 |
| Davis Krista | SVP, CHIEF HR OFFICER | F | 1,180 | $77 | $91K | Feb 17 |
▶
2026-02-14
8 other
⚡ 8 insiders
| Insider | Title | Type | Shares | Price | $ Value | 10b5-1 | Filed |
|---|---|---|---|---|---|---|---|
| Rowland Thomas Andrew | SVP, HEAD - ESTABLISHED BRANDS | F | 485 | $77 | $38K | Feb 17 | |
| CAREY STEPHEN P. | SVP & CFO | F | 2,448 | $77 | $189K | Feb 17 | |
| Lalwani Nikhil | PRESIDENT & CEO | F | 10,298 | $77 | $797K | Feb 17 | |
| Gutwerg Ori | SVP, GENERICS | F | 1,888 | $77 | $146K | Feb 17 | |
| Mutz Christopher | HEAD OF RARE DISEASE | F | 2,403 | $77 | $186K | Plan | Feb 17 |
| Gassert Chad | SVP - CORP. DEV. & STRATEGY | F | 1,717 | $77 | $133K | Feb 17 | |
| Cook Meredith | SR. VP, GENERAL COUNSEL & SEC. | F | 1,779 | $77 | $138K | Plan | Feb 17 |
| Davis Krista | SVP, CHIEF HR OFFICER | F | 1,290 | $77 | $100K | Feb 17 |
▶
2026-02-13
▼ 1 sell
· $38K
| Insider | Title | Type | Shares | Price | $ Value | 10b5-1 | Filed |
|---|---|---|---|---|---|---|---|
| Cook Meredith | SR. VP, GENERAL COUNSEL & SEC. | ▼ Sell | 500 | $77 | $38K | Plan | Feb 17 |
▶
2026-02-11
9 other
⚡ 9 insiders
| Insider | Title | Type | Shares | Price | $ Value | 10b5-1 | Filed |
|---|---|---|---|---|---|---|---|
| Rowland Thomas Andrew | SVP, HEAD - ESTABLISHED BRANDS | F | 1,762 | $76 | $134K | Feb 13 | |
| CAREY STEPHEN P. | SVP & CFO | F | 5,503 | $76 | $420K | Feb 13 | |
| Lalwani Nikhil | PRESIDENT & CEO | F | 30,659 | $76 | $2.3M | Feb 13 | |
| Gutwerg Ori | SVP, GENERICS | F | 4,267 | $76 | $325K | Feb 13 | |
| Mutz Christopher | HEAD OF RARE DISEASE | F | 4,546 | $76 | $347K | Feb 13 | |
| Shanmugam Muthusamy | HEAD OF R&D, COO-NOVITIUM OPS | F | 2,898 | $76 | $221K | Feb 13 | |
| Gassert Chad | SVP - CORP. DEV. & STRATEGY | F | 4,269 | $76 | $326K | Feb 13 | |
| Cook Meredith | SR. VP, GENERAL COUNSEL & SEC. | F | 3,011 | $76 | $230K | Feb 13 | |
| Davis Krista | SVP, CHIEF HR OFFICER | F | 3,017 | $76 | $230K | Feb 13 |